Clinical Trials Directory

Trials / Completed

CompletedNCT01832194

Use of Botox to Treat Scrotal Pain

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Mount Sinai Hospital, Canada · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

There are no previous reports on the use of Onabotulinum Toxin A to treat men with scrotal pain that we found published. We propose a pilot study to use Botox to block the testicular nerves on a group of 15 men with chronic scrotal pain who have failed the standard medical therapy. The men must have had temporary relief from a testicular cord block using marcaine. Before and 1 month, 3 months and 6 months after the Onabotulinum Toxin A injection, the men would be asked to fill in visual analog scales for pain, a quality of life assessment, a depression index (MDI) and Chronic Epididymitis Symptom Index (CESI). They will also be subject to sensory testing of the scrotum before, after 1 month, 3 moths and 6 months.

Conditions

Interventions

TypeNameDescription
DRUGBotox

Timeline

Start date
2013-03-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2013-04-15
Last updated
2014-09-01

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01832194. Inclusion in this directory is not an endorsement.